Dynavax Technologies Corporation (DVAX)

19.85
0.25 1.30
NASDAQ
Prev Close 19.60
Open 19.20
Day Low/High 18.90 / 20.27
52 Wk Low/High 3.58 / 20.66
Volume 5.20M
Exchange NASDAQ
Shares Outstanding 114.76B
Market Cap 2.16B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

There's Good News for 3 Biotech Names

There's Good News for 3 Biotech Names

And It comes after one of the best days of the year for the biotech sector.

Taiwan Administers First Home-Made Vaccine

Taiwan Administers First Home-Made Vaccine

Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.

Here's What to Do When You Don't Have Strong Conviction in the Markets

Here's What to Do When You Don't Have Strong Conviction in the Markets

Sometimes it's best to move to the sidelines until something changes.

2 Biotech Stocks to Watch

2 Biotech Stocks to Watch

Dynavax Technologies and Albireo Pharma are names for consideration while investors wait for sentiment on the biotech sector to eventually turn around.

It's Time for Bargain Shopping in the Biotech Aisle

It's Time for Bargain Shopping in the Biotech Aisle

Dynavax Technologies, Kala Pharmaceuticals and TherapeuticsMD are three names this biotech investor plans to add exposure to via covered calls.

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.

2 Small Biotechs Face Crossroads Years in 2020

2 Small Biotechs Face Crossroads Years in 2020

Dynavax Technologies and Omeros Corp. have tested shareholders' patience over time and again are at inflection points.

A Trio of Small Biotech Companies Garnering Attention

A Trio of Small Biotech Companies Garnering Attention

The three either have made recent progress toward advancing products in their pipelines or have caught the eye of analysts.

2 Small Biotechs With Sagging Shares but Promising Prospects

2 Small Biotechs With Sagging Shares but Promising Prospects

The stocks of these two developmental concerns have slid recently, but there are reasons to believe they will improve.

Hopeful Signs for These 2 Small Biotech Stocks

Hopeful Signs for These 2 Small Biotech Stocks

Few parts of this biotech space are more frustrating that what I have dubbed 'Tier 3' biotech concerns.

3 Biotech Stocks Boasting Earnings Beats - and Healthy Outlooks

3 Biotech Stocks Boasting Earnings Beats - and Healthy Outlooks

Quick takes on fourth-quarter results from these 3 biotech names.

2 Small-Caps That Should Continue to Stage Comebacks in 2019

2 Small-Caps That Should Continue to Stage Comebacks in 2019

Beaten-down Entercom Communications and Dynavax Technologies are off to good starts this year and should continue to improve.

Buy Struggling Progenics and Dynavax Here

Buy Struggling Progenics and Dynavax Here

Both biotech stocks are at or near 52-week lows, but don't deserve to be.

Seeking Bargains on Last Week's Selloff

Seeking Bargains on Last Week's Selloff

These 5 stocks are a good value on this weakness.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

Biotech Bargains: Two Cheap Small-Cap Stocks in an Exciting Sector

Biotech Bargains: Two Cheap Small-Cap Stocks in an Exciting Sector

I continue to see these names as bargains in the biotech and biopharma space.

Small Cap Biotech Bargains

Small Cap Biotech Bargains

Here are 2 small caps I continue to see as bargains in this space.

4 Names to Watch Ahead of This Year's Key Cancer-Research Conference

4 Names to Watch Ahead of This Year's Key Cancer-Research Conference

These names are moving up or down in a big way ahead of releasing drug-trial results.

4 Names to Watch Ahead of Cancer Conference

4 Names to Watch Ahead of Cancer Conference

American Society of Clinical Oncology will see presentations from dozens of companies.

4 Names to Buy in a Refreshed Biotech Space

4 Names to Buy in a Refreshed Biotech Space

After a strong week for the biotech sector, these names have potential catalysts to move shares.

Watch Oncology Stocks Ahead of 2 Big Events

Watch Oncology Stocks Ahead of 2 Big Events

Data and industry conferences will likely be catalysts for shares in the space.

3 Favorite Biotech Stocks for the Second Quarter

3 Favorite Biotech Stocks for the Second Quarter

Your questions are answered in our latest addition of the biotech mailbag.

Watch These Biotechs and the FDA Calendar

Watch These Biotechs and the FDA Calendar

Here are a few key events I will be watching closely for in the months ahead on stocks I think are buys at current levels.

3 Key Biotech Catalysts on the FDA Calendar

3 Key Biotech Catalysts on the FDA Calendar

A roundup of biotech names with actions pending at the FDA in coming weeks.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

5 Small Biotechs Receive Shots in the Arm

5 Small Biotechs Receive Shots in the Arm

Favorable quarterly results and FDA drug approvals should help lift these five names.

Acadia, Dynavax Make the Biotech Mailbag

Acadia, Dynavax Make the Biotech Mailbag

Readers have asked about Acadia Pharmaceuticals and Dynavax Technologies, so we answer.

These 4 Small Biotechs Have Big Upcoming Catalysts

These 4 Small Biotechs Have Big Upcoming Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on these events.